New Hope for Liver Disease Patients as Diabetes Drug Semaglutide Shows Promising Results
A recent international clinical trial has revealed that semaglutide, a medication commonly used to treat diabetes and help with weight loss, could also be effective in treating a serious type of fatty liver disease known as metabolic dysfunction-associated steatohepatitis (MASH). This condition, which causes fat buildup, inflammation, and scarring in the liver, affects millions worldwide